Outbreak Brief 96: Coronavirus Disease 2019 (COVID-19) Pandemic

  • Version
  • Download 5069
  • File Size 3.04 MB
  • File Count 3
  • Create Date 18 November 2021
  • Last Updated 20 November 2021

Outbreak Brief 96: Coronavirus Disease 2019 (COVID-19) Pandemic

Outbreak Update: Since the last brief (9 November 2021), 3,915,756 new confirmed1 coronavirus disease 2019 (COVID-19) cases, including 57,391 new deaths, have been reported globally. To date, a global total of 253,619,757 COVID-19 cases and 5,105,451 related deaths (case fatality ratio (CFR): 2%) have been reported by 226 countries and territories to the World Health Organization (WHO). The distribution of cumulative cases (proportion of global cases) from the WHO reporting regions (excluding Africa) are as follows: Eastern Mediterranean Region 14,140,266 (6%), European Region 81,537,428 (32%), Region of the Americas 95,227,417 (38%), South-East Asia Region 44,309,408 (17%) and Western Pacific Region 9,817,769 (4%). In the last seven days, the five countries reporting the highest number of new cases globally are the United States (602,327), Germany (285,896), the Russian Federation (270,825), the United Kingdom (270,514), and Turkey (168,954). For more detailed information on cases and deaths reported outside of Africa, refer to the WHO COVID-19 dashboard.

Attached Files

FileAction
Africa CDC COVID-19 Brief 16 Nov 21 - ARDownload
Africa CDC COVID-19 Brief 16 Nov 21 - ENDownload
Africa CDC COVID-19 Brief 16 Nov 21 - FRDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload